Literature DB >> 13341903

2-Hydroxymethyl-3-methylquinoxaline 1:4-dioxide: a metabolite of 2:3-dimethylquinoxaline 1:4-dioxide active against gram-negative bacteria.

J FRANCIS, J K LANDQUIST, A A LEVI, J A SILK, J M THORP.   

Abstract

Entities:  

Keywords:  BACTERIA/effect of drugs on; BENZENE/derivatives; URINE

Mesh：

Substances：

Year:  1956        PMID： 13341903      PMCID： PMC1216194          DOI： 10.1042/bj0630455

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  3 in total

1.  The treatment of experimental bacillary infections of mice with quinoxaline 1:4 di-N-oxide.

Authors:  C E COULTHARD; L J HALE
Journal:  Br J Pharmacol Chemother       Date:  1955-09

2.  Synthetic amoebicides. II. The anti-amoebic action of quinoxaline-1:4-dioxide and some derivatives.

Authors:  W R JONES; J K LANDQUIST; G T STEWART
Journal:  Br J Pharmacol Chemother       Date:  1953-09

3.  The therapy of experimental psittacosis and lymphogranuloma venereum (inguinale) II. The activity of quinoxaline-1:4-dioxide and substituted and related compounds, with a note on the morphological changes induced in lymphogranuloma virus by these compounds and by antibiotics.

Authors:  E W HURST; J K LANDQUIST; P MELVIN; J M PETERS; N SENIOR; J A SILK; G J STACY
Journal:  Br J Pharmacol Chemother       Date:  1953-09
  3 in total
  1 in total

1.  Synthesis, In-Vitro Activity and Metabolic Properties of Quinocetone and Structurally Similar Compounds.

Authors:  Keyu Zhang; Chunmei Wang; Xiaoyang Wang; Haihong Zheng; Juan Zhao; Mi Wang; Sui Xiao; Chenzhong Fei; Wenli Zheng; Lifang Zhang; Feiqun Xue
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.